BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22158522)

  • 1. The antitumor effects of adenoviral-mediated, intratumoral delivery of interleukin 23 require endogenous IL-12.
    Reay J; Gambotto A; Robbins PD
    Cancer Gene Ther; 2012 Feb; 19(2):135-43. PubMed ID: 22158522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenoviral-mediated, intratumor gene transfer of interleukin 23 induces a therapeutic antitumor response.
    Reay J; Kim SH; Lockhart E; Kolls J; Robbins PD
    Cancer Gene Ther; 2009 Oct; 16(10):776-85. PubMed ID: 19390568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic and specific antitumor immunity induced by co-administration of immature dendritic cells and adenoviral vector expressing biologically active IL-18.
    Tanaka F; Hashimoto W; Robbins PD; Lotze MT; Tahara H
    Gene Ther; 2002 Nov; 9(21):1480-6. PubMed ID: 12378411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single intratumoral injection of a fiber-mutant adenoviral vector encoding interleukin 12 induces remarkable anti-tumor and anti-metastatic activity in mice with Meth-A fibrosarcoma.
    Gao JQ; Sugita T; Kanagawa N; Iida K; Eto Y; Motomura Y; Mizuguchi H; Tsutsumi Y; Hayakawa T; Mayumi T; Nakagawa S
    Biochem Biophys Res Commun; 2005 Mar; 328(4):1043-50. PubMed ID: 15707983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12.
    Gambotto A; Tüting T; McVey DL; Kovesdi I; Tahara H; Lotze MT; Robbins PD
    Cancer Gene Ther; 1999; 6(1):45-53. PubMed ID: 10078963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-Y, a synthetic member of the IL-12 cytokine family, suppresses the development of type 1 diabetes in NOD mice.
    Flores RR; Kim E; Zhou L; Yang C; Zhao J; Gambotto A; Robbins PD
    Eur J Immunol; 2015 Nov; 45(11):3114-25. PubMed ID: 26260044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated interleukin-12 gene transfer combined with cytosine deaminase followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice.
    Hwang KS; Cho WK; Yoo J; Yun HJ; Kim S; Im DS
    BMC Cancer; 2005 May; 5():51. PubMed ID: 15910693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic adenovirus expressing IL-23 and p35 elicits IFN-γ- and TNF-α-co-producing T cell-mediated antitumor immunity.
    Choi IK; Li Y; Oh E; Kim J; Yun CO
    PLoS One; 2013; 8(7):e67512. PubMed ID: 23844018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose adenoviral immunotherapy of rat hepatocellular carcinoma using single-chain interleukin-12.
    Waehler R; Ittrich H; Mueller L; Krupski G; Ameis D; Schnieders F
    Hum Gene Ther; 2005 Mar; 16(3):307-17. PubMed ID: 15812226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local and systemic antitumor effect of intratumoral and peritumoral IL-12 electrogene therapy on murine sarcoma.
    Pavlin D; Cemazar M; Kamensek U; Tozon N; Pogacnik A; Sersa G
    Cancer Biol Ther; 2009 Nov; 8(22):2114-22. PubMed ID: 19755854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer immunotherapy using a membrane-bound interleukin-12 with B7-1 transmembrane and cytoplasmic domains.
    Pan WY; Lo CH; Chen CC; Wu PY; Roffler SR; Shyue SK; Tao MH
    Mol Ther; 2012 May; 20(5):927-37. PubMed ID: 22334018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer.
    Chen L; Chen D; Block E; O'Donnell M; Kufe DW; Clinton SK
    J Immunol; 1997 Jul; 159(1):351-9. PubMed ID: 9200473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model.
    Miyahara R; Banerjee S; Kawano K; Efferson C; Tsuda N; Miyahara Y; Ioannides CG; Chada S; Ramesh R
    Cancer Gene Ther; 2006 Aug; 13(8):753-61. PubMed ID: 16543916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models.
    Emtage PC; Wan Y; Hitt M; Graham FL; Muller WJ; Zlotnik A; Gauldie J
    Hum Gene Ther; 1999 Mar; 10(5):697-709. PubMed ID: 10210138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitizing effect of intratumoral interleukin-12 gene electrotransfer in murine sarcoma.
    Sedlar A; Kranjc S; Dolinsek T; Cemazar M; Coer A; Sersa G
    BMC Cancer; 2013 Jan; 13():38. PubMed ID: 23360213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent antitumor effects mediated by local expression of the mature form of the interferon-gamma inducing factor, interleukin-18 (IL-18).
    Osaki T; Hashimoto W; Gambotto A; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H
    Gene Ther; 1999 May; 6(5):808-15. PubMed ID: 10505105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid cancer immuno-therapy with retroviral and adenoviral vectors expressing granulocyte macrophage colony stimulating factor and interleukin-12 in a rat model.
    Tanaka K; Towata S; Nakao K; Mizuguchi H; Hayakawa T; Niwa M; Ishii N; Nagayama Y
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):734-42. PubMed ID: 14974915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα.
    Choi IK; Lee JS; Zhang SN; Park J; Sonn CH; Lee KM; Yun CO
    Gene Ther; 2011 Sep; 18(9):898-909. PubMed ID: 21451575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of interleukin-12 gene-based tumor immunotherapy by the reduced secretion of p40 subunit and the combination with farnesyltransferase inhibitor.
    Jin HT; Youn JI; Kim HJ; Lee JB; Ha SJ; Koh JS; Sung YC
    Hum Gene Ther; 2005 Mar; 16(3):328-38. PubMed ID: 15812228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation.
    Chen L; Chen H; Ye J; Ge Y; Wang H; Dai E; Ren J; Liu W; Ma C; Ju S; Guo ZS; Liu Z; Bartlett DL
    Theranostics; 2021; 11(14):6668-6681. PubMed ID: 34093846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.